原发性肝癌合并门静脉癌栓的综合介入治疗效果

Comprehensive Interventional Therapy of Primary Liver Cancer Complicated With Portal Vein Tumor Thrombus

目的原发性肝癌合并门静脉癌栓的综合介入治疗的临床效果。方法选取在科室进行原发性肝癌合并门静脉癌栓治疗的86例患者进行调查与分析,调查时间为2016年2月-2019年3月。将患者分为2组,每组43例。对比组采用常规经导管肝动脉化疗栓塞治疗,试验组采用综合介入治疗方式。分析两组最终治疗结果。结果对比组不良反应发生率为32.56%与试验组的6.98%相比较低(P<0.05);对比组一年生存率、两年生存率、三年生存率和试验组相比较低(P<0.05)。结论在原发性肝癌合并门静脉癌栓治疗中,综合介入治疗方式应当做首选治疗方案,实施效果优异,值得临床应用与普及。

Objective To evaluate the clinical effect of comprehensive interventional therapy for primary liver cancer with portal vein tumor thrombus.Methods 86 patients with primary liver cancer combined with portal vein tumor thrombus were selected for investigation and analysis,The investigation time was from May 2016 to May 2019,The patients were divided into two groups,43 cases in each group,The control group was treated with conventional transcatheter arterial chemoembolization,and the experimental group was treated with comprehensive interventional therapy,The final treatment results of the two groups were analyzed,Results The incidence of adverse reactions in the control group was 32.56%,which was lower than that in the experimental group(6.98%),The difference between the two groups was obvious(P<0.05);the one-year survival rate,two-year survival rate,three-year survival rate and the experimental group were lower(P<0.05),Conclusion In the treatment of primary liver cancer with portal vein tumor thrombus,the first choice should be the comprehensive interventional therapy.